Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study

被引:13
|
作者
Song, Jie [1 ]
Westerlind, Helga [2 ,3 ]
McKay, Kyla A. [4 ]
Almqvist, Catarina [1 ,5 ]
Stridh, Pernilla [6 ]
Kockum, Ingrid [6 ]
Hillert, Jan [4 ]
Manouchehrinia, Ali [4 ,6 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[2] Karolinska Inst, Inst Environm Med, Unit Cardiovasc Epidemiol, Stockholm, Sweden
[3] Karolinska Inst, Dept Med, Div Clin Epidemiol, Stockholm, Sweden
[4] Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med, Stockholm, Sweden
[5] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Lung & Allergy Unit, Stockholm, Sweden
[6] Karolinska Inst, Ctr Mol Med, Karolinska Neuroimmunol & Multiple Sclerosis Ctr, Dept Clin Neurosci, Stockholm, Sweden
基金
加拿大健康研究院;
关键词
Multiple sclerosis; Familial risk; Genetics; Early onset; Late onset; GENETIC RISK; AGE; POPULATION;
D O I
10.1007/s00415-018-9163-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundPersons who develop multiple sclerosis (MS) at a young age may bear a higher genetic risk load than persons who develop MS later in life; however, the contribution of familial influence to the risk of MS, in relation to onset age, has not been established.ObjectiveTo investigate the familial risk of MS at two extremes of the spectrum of MS onset age: early onset (first MS symptom <18years of age) and late onset (first MS symptom 50years).MethodsNationwide registries in Sweden were used to identify cases of MS and controls, and their familial relations. We estimated the odds ratio (OR) of an MS diagnosis for individuals with a relative diagnosed with early-onset or late-onset MS compared with those whose relatives did not have MS, using a nested case-control design.Results629 early-onset and 1148 late-onset MS patients were identified and matched to 10 controls from the general population by age and sex. The OR of MS for individuals with a first-degree relative diagnosed with early-onset MS was 10.86 (95% CI 6.87-17.17); and for late-onset MS was 8.08 (95% CI 6.12-10.67).ConclusionsOur findings demonstrate no substantial differences in familial risk in persons with early- and late-onset MS.
引用
收藏
页码:481 / 486
页数:6
相关论文
共 50 条
  • [1] Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study
    Jie Song
    Helga Westerlind
    Kyla A. McKay
    Catarina Almqvist
    Pernilla Stridh
    Ingrid Kockum
    Jan Hillert
    Ali Manouchehrinia
    [J]. Journal of Neurology, 2019, 266 : 481 - 486
  • [2] Clinical and demographic characteristics of patients with early- and late-onset multiple sclerosis
    Sen, S.
    Terzi, M.
    Can, N.
    Cavit, B.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 317 - 318
  • [3] Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis
    Mirmosayyeb, Omid
    Brand, Serge
    Barzegar, Mahdi
    Afshari-Safavi, Alireza
    Nehzat, Nasim
    Shaygannejad, Vahid
    Bahmani, Dena Sadeghi
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
  • [4] Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis A Swedish Nationwide Study
    Mouresan, Elena F.
    Mentesidou, Eleni
    Berglund, Anders
    Mckay, Kyla A.
    Hillert, Jan
    Iacobaeus, Ellen
    [J]. NEUROLOGY, 2024, 102 (06)
  • [5] Familial aggregation of early- and late-onset Parkinson's disease
    Marder, K
    Levy, G
    Louis, ED
    Mejia-Santana, H
    Cote, L
    Andrews, H
    Harris, J
    Waters, C
    Ford, B
    Frucht, S
    Fahn, S
    Ottman, R
    [J]. ANNALS OF NEUROLOGY, 2003, 54 (04) : 507 - 513
  • [6] Risk Factors for Early- and Late-Onset Superimposed Preeclampsia
    Onishi, Kazuma
    Seagraves, Elizabeth
    Baraki, Dana
    Donaldson, Thomas
    Barake, Carole
    Abuhamad, Alfred
    Huang, Jim C.
    Kawakita, Tetsuya
    [J]. AMERICAN JOURNAL OF PERINATOLOGY, 2024, 41 : e2073 - e2080
  • [7] Rituximab- and ocrelizumab-induced early- and late-onset neutropenia in a multiple sclerosis patient
    Marrodan, Mariano
    Laviano, Julia
    Oneto, Sofia
    Reino, Fabricio M.
    Delorme, Ricardo
    Fornillo, Florencia
    Fernandez, Jose
    Correale, Jorge
    [J]. NEUROLOGICAL SCIENCES, 2021, 42 (09) : 3893 - 3895
  • [8] Rituximab- and ocrelizumab-induced early- and late-onset neutropenia in a multiple sclerosis patient
    Mariano Marrodan
    Julia Laviano
    Sofía Oneto
    Fabricio M. Reino
    Ricardo Delorme
    Florencia Fornillo
    José Férnandez
    Jorge Correale
    [J]. Neurological Sciences, 2021, 42 : 3893 - 3895
  • [9] Late-onset multiple sclerosis
    Ketata, Imen
    Dorgham, Dorra
    Bouaziz, Fatma
    Sellami, Rahma
    Ellouz, Emna
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [10] Late-onset multiple sclerosis
    Polliack, ML
    Barak, Y
    Achiron, A
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (02) : 168 - 171